Results 181 to 190 of about 17,830 (294)

Hyperuricemia and Urologic Disease

open access: yesUrogenital Tract Infection, 2017
In-Chang Cho, Seung Ki Min
openaire   +1 more source

The LaserSAFE technique for margin assessment during radical prostatectomy: a feasibility study

open access: yesBJU International, EarlyView.
Objectives To assess the feasibility of conducting a multicentre trial comparing NeuroSAFE with a novel technique based on confocal laser microscopy (LaserSAFE) and evaluate the diagnostic performance of LaserSAFE for real‐time surgical margin assessment.
Ricardo Almeida‐Magana   +15 more
wiley   +1 more source

The cost‐effectiveness of intraoperative margin assessment strategies during radical prostatectomy

open access: yesBJU International, EarlyView.
Objective To determine whether current intraoperative margin assessment (IOMA) techniques (such as Neurovascular Structure Adjacent Frozen‐section Examination [NeuroSAFE] or confocal laser microscopy [CLM]) used during radical prostatectomy (RP) to enhance nerve‐sparing surgery (NSS) while reducing positive surgical margins (PSMs) justify their extra ...
Joost van Drumpt   +7 more
wiley   +1 more source

Impact of positive surgical margins on biochemical recurrence and metastases after radical prostatectomy

open access: yesBJU International, EarlyView.
Objectives To evaluate the impact of the presence, extent and location of positive surgical margins (PSMs) on the risk of biochemical recurrence (BCR) and metastases in a nationwide cohort of patients who underwent radical prostatectomy (RP) and had 5 years of follow‐up.
Joost van Drumpt   +10 more
wiley   +1 more source

Urologic malignancy risk with chronic tumor necrosis factor-alpha inhibitor (TNF-I) exposure: a multicenter, retrospective cohort study. [PDF]

open access: yesWorld J Urol
Driscoll CB   +12 more
europepmc   +1 more source

Focal therapy using a novel cooled laser device for prostate cancer: early trial results

open access: yesBJU International, EarlyView.
Objectives To determine the short‐term oncological results and safety of the ProFocal Laser Therapy for Prostate Tissue Ablation (PFLT‐PC) trial, the first phase II clinical trial of ProFocal® (Medlogical Innovations, Sydney, Australia), a novel, cooled laser focal therapy (cLFT) device for prostate cancer (PCa) treatment. Patients and Methods Men with
Jonathan Kam   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy